A comprehensive view of Cybin Inc. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
GlobalData expects psychedelic drug market to hit US$7.2B by 2029, reflecting 55% CAGR and driven by positive regulatory changes; by 2029, top drugs expected to be Atai Life Sciences/Otsuka Pharmaceutical's PCN-101, Cybin's CYB-003, Small Pharma's SPL-026
Published:
September 26, 2023
by GlobalData Plc
|
Ask us about our Health Care Sector market view